Postpartum Anemia Clinical Trial
Official title:
A Multicenter, Randomized, Double-blind, Parallel Controlled Clinical Study on the Efficacy and Safety of Compound E Jiao Jiang(cEJJ)in the Treatment of Postpartum Anemia
The goal of this clinical trial] is to compare the effect of compound E Jiao Jiang(cEJJ)combined with iron decoction on postpartum anemia.The main questions it aims to answer are: To evaluate the effectiveness of compound E Jiao Jiang(cEJJ) in the treatment of postpartum anemia. To evaluate the safety of compound E Jiao Jiang(cEJJ) in the treatment of postpartum anemia. To explore the effect of compound ejiao decoction on improving anxiety, depression, sleep and fatigue in postpartum anemia patients. Participants will be randomly assigned (like flipping a coin) to either the trial group or the control group (with a 50% chance of being assigned to either group), where the trial group will receive the compound E Jiao Jiang(cEJJ) + ferrous succinate tablet, and the control group will receive the compound E Jiao Jiang(cEJJ)placebo + ferrous succinate tablet. The compound E Jiao Jiang(cEJJ)placebo is the same/similar to the compound E Jiao Jiang(cEJJ) in terms of appearance, smell and taste, but has no therapeutic effect.And participants need to return to the research center on time for relevant examinations according to the protocol requirements.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05590260 -
Prevention of Iron Deficiency Anemia Post-delivery
|
Phase 3 | |
Completed |
NCT01628770 -
Use of Iron Isomaltoside 1000 (Monofer) in Postpartum Anemia
|
N/A | |
Completed |
NCT00354484 -
Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients
|
Phase 3 | |
Recruiting |
NCT02656225 -
Effect of Ejiao Compound in the Treatment of Postpartum Anemia of Qi-blood Deficiency Syndrome
|
Phase 1/Phase 2 | |
Completed |
NCT02434653 -
A Comparison Between Two Strategies for Postpartum Anemia Diagnosis and Follow up After Vaginal Deliveries
|
N/A | |
Completed |
NCT02458625 -
A Comparison Between Intravenous Iron Sucrose to Its Combination With Oral Iron Supplements for the Treatment of Postpartum Anemia
|
N/A |